Savara Inc (SVRA) stock
SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$4.72+0.24 (+5.36%)
Close on Nov 18, 2026Market cap $969.77MP/E –Yield –
Savara total assets
Total assets on the balance sheet at the end of each period.
Savara's total assets was $192.14M at Jun 30, 2026. For fiscal 2025 it was $253.44M, up 19.1% from the year before. Over ten years it grew 16.7% a year on average. The highest annual figure on record is $253.44M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $253.44M | +19.1% |
| FY2024 | Dec 31, 2024 | $212.88M | +19.9% |
| FY2023 | Dec 31, 2023 | $177.56M | +27.0% |
| FY2022 | Dec 31, 2022 | $139.78M | -20.9% |
| FY2021 | Dec 31, 2021 | $176.60M | +80.7% |
| FY2020 | Dec 31, 2020 | $97.75M | -28.2% |
| FY2019 | Dec 31, 2019 | $136.20M | -10.6% |
| FY2018 | Dec 31, 2018 | $152.29M | -4.6% |
| FY2017 | Dec 31, 2017 | $159.63M | +451.7% |
| FY2016 | Dec 31, 2016 | $28.93M | -46.6% |
| FY2015 | Dec 31, 2015 | $54.22M | -23.1% |
| FY2014 | Dec 31, 2014 | $70.50M | +27.6% |
| FY2013 | Dec 31, 2013 | $55.25M | +17.6% |
| FY2012 | Dec 31, 2012 | $46.97M | -24.1% |
| FY2011 | Dec 31, 2011 | $61.86M | +117.1% |
| FY2010 | Dec 31, 2010 | $28.49M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $192.14M | +17.3% |
| Q1 FY2026 | Mar 31, 2026 | $221.65M | +17.1% |
| Q4 FY2025 | Dec 31, 2025 | $253.44M | +19.1% |
| Q3 FY2025 | Sep 30, 2025 | $140.92M | -41.0% |
| Q2 FY2025 | Jun 30, 2025 | $163.77M | +17.3% |
| Q1 FY2025 | Mar 31, 2025 | $189.32M | +19.6% |
| Q4 FY2024 | Dec 31, 2024 | $212.88M | +19.9% |
| Q3 FY2024 | Sep 30, 2024 | $238.82M | +31.2% |
| Q2 FY2024 | Jun 30, 2024 | $139.67M | +16.6% |
| Q1 FY2024 | Mar 31, 2024 | $158.30M | +22.4% |
| Q4 FY2023 | Dec 31, 2023 | $177.56M | +27.0% |
| Q3 FY2023 | Sep 30, 2023 | $182.07M | +23.2% |
| Q2 FY2023 | Jun 30, 2023 | $119.83M | -23.6% |
| Q1 FY2023 | Mar 31, 2023 | $129.36M | -22.2% |
| Q4 FY2022 | Dec 31, 2022 | $139.78M | -20.9% |
| Q3 FY2022 | Sep 30, 2022 | $147.76M | -21.1% |
| Q2 FY2022 | Jun 30, 2022 | $156.78M | -20.2% |
| Q1 FY2022 | Mar 31, 2022 | $166.21M | -19.9% |
| Q4 FY2021 | Dec 31, 2021 | $176.60M | +80.7% |
| Q3 FY2021 | Sep 30, 2021 | $187.27M | +71.3% |
| Q2 FY2021 | Jun 30, 2021 | $196.43M | +70.6% |
| Q1 FY2021 | Mar 31, 2021 | $207.63M | +73.1% |
| Q4 FY2020 | Dec 31, 2020 | $97.75M | -28.2% |
| Q3 FY2020 | Sep 30, 2020 | $109.34M | -22.2% |
| Q2 FY2020 | Jun 30, 2020 | $115.15M | -21.8% |
| Q1 FY2020 | Mar 31, 2020 | $119.98M | -19.1% |
| Q4 FY2019 | Dec 31, 2019 | $136.20M | -10.6% |
| Q3 FY2019 | Sep 30, 2019 | $140.63M | -9.3% |
| Q2 FY2019 | Jun 30, 2019 | $147.33M | +24.9% |
| Q1 FY2019 | Mar 31, 2019 | $148.26M | +15.0% |
| Q4 FY2018 | Dec 31, 2018 | $152.29M | -4.6% |
| Q3 FY2018 | Sep 30, 2018 | $155.12M | +30.5% |
| Q2 FY2018 | Jun 30, 2018 | $117.94M | -6.2% |
| Q1 FY2018 | Mar 31, 2018 | $128.87M | +828.1% |
| Q4 FY2017 | Dec 31, 2017 | $159.63M | +451.7% |
| Q3 FY2017 | Sep 30, 2017 | $118.89M | +196.3% |
| Q2 FY2017 | Jun 30, 2017 | $125.77M | – |
| Q1 FY2017 | Mar 31, 2017 | $13.89M | – |
| Q4 FY2016 | Dec 31, 2016 | $28.93M | – |
| Q3 FY2016 | Sep 30, 2016 | $40.12M | – |
See a number that looks wrong?